January 13Jan 13 Illumina has introduced a new dataset to speed up drug discovery using artificial intelligence. This initiative involves major drugmakers like AstraZeneca, Merck, and Eli Lilly. The dataset will train advanced AI models to understand diseases better. This development aligns with efforts to reduce animal testing. Companies are increasingly using AI for faster and cheaper drug development. View the full article
Create an account or sign in to comment